Metal-catalyzed oxidative damage and oligomerization of the amyloid-peptide of Alzheimer's disease

被引:25
作者
Ali, FEA
Barnham, KJ
Barrow, CJ
Separovic, F [1 ]
机构
[1] Univ Melbourne, Sch Chem, Melbourne, Vic 3010, Australia
[2] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia
关键词
D O I
10.1071/CH04026
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The most common form of dementia in old age is Alzheimer's disease ( AD). The presence in the brain of senile plaque is the major pathological marker of AD. The plaques are primarily composed of aggregated amyloid-beta peptide (Abeta). Abeta is a 40 - 42 amino acid peptide that is a proteolytic product derived from the beta-amyloid precursor protein. The function of Abeta and the exact mechanism of Abeta aggregation and neurotoxicity are unclear. However, metal coordination by Abeta plays an important role in inducing aggregation and the generation of reactive oxygen species, which appears to be at least partially responsible for Abeta neurotoxicity. In this review we examine the role of copper and zinc ions in Abeta neurotoxicity, especially with regards to the generation of free radicals. We discuss the role of copper or zinc ions in oxidative damage and Abeta conformational changes and the relationship of these metals to AD.
引用
收藏
页码:511 / 518
页数:8
相关论文
共 118 条
[71]   Protein oxidation and ageing [J].
Linton, S ;
Davies, MJ ;
Dean, RT .
EXPERIMENTAL GERONTOLOGY, 2001, 36 (09) :1503-1518
[72]  
Liochev SI, 1999, MET IONS BIOL SYST, V36, P1
[73]   Histidine-13 is a crucial residue in the zinc ion-induced aggregation of the Aβ peptide of Alzheimer's disease [J].
Liu, ST ;
Howlett, G ;
Barrow, CJ .
BIOCHEMISTRY, 1999, 38 (29) :9373-9378
[74]   Copper, iron and zinc in Alzheimer's disease senile plaques [J].
Lovell, MA ;
Robertson, JD ;
Teesdale, WJ ;
Campbell, JL ;
Markesbery, WR .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1998, 158 (01) :47-52
[75]  
MAGURA IS, 1997, BIOPOLYM CELL, V13, P513, DOI DOI 10.7124/BC.0004B0
[76]   ALUMINUM, IRON, AND ZINC IONS PROMOTE AGGREGATION OF PHYSIOLOGICAL CONCENTRATIONS OF BETA-AMYLOID PEPTIDE [J].
MANTYH, PW ;
GHILARDI, JR ;
ROGERS, S ;
DEMASTER, E ;
ALLEN, CJ ;
STIMSON, ER ;
MAGGIO, JE .
JOURNAL OF NEUROCHEMISTRY, 1993, 61 (03) :1171-1174
[77]   Science, medicine, and the future - Alzheimer's disease [J].
Masters, CL ;
Beyreuther, K .
BRITISH MEDICAL JOURNAL, 1998, 316 (7129) :446-448
[78]  
MATTSON MP, 1997, ALZHEIMERS DIS REV, V2, P1
[79]   Review:: Modulating factors in amyloid-β fibril formation [J].
McLaurin, J ;
Yang, DS ;
Yip, CM ;
Fraser, PE .
JOURNAL OF STRUCTURAL BIOLOGY, 2000, 130 (2-3) :259-270
[80]   Mitochondrial membrane fluidity and oxidative damage to mitochondrial DNA in aged and AD human brain [J].
Mecocci, P ;
Beal, MF ;
Cecchetti, R ;
Polidori, MC ;
Cherubini, A ;
Chionne, F ;
Avellini, L ;
Romano, G ;
Senin, U .
MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1997, 31 (01) :53-64